Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110αRomain Baer, Julie Guillermet‐Guibert, Célia Cintas et al.|Genes & Development|2014Cited by 127
FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancerSonia Zaghdoudi, Christine Jean, Stéphane Pyronnet et al.|EMBO Molecular Medicine|2020Cited by 105
Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16Mounira Chalabi‐Dchar, Corinne Bousquet, Stéphanie Cassant‐Sourdy et al.|Gastroenterology|2015Cited by 46
Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblastsSiham Moatassim-Billah, Corinne Bousquet, Camille Duluc et al.|Oncotarget|2016Cited by 39
Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With MacrophagesRémi Samain, Corinne Bousquet, Alexia Brunel et al.|Cellular and Molecular Gastroenterology and Hepatology|2021Cited by 32